Brain-computer interface sees a major breakthrough: retinal chip approved for listing in Europe, helping patients regain vision

robot
Abstract generation in progress
Golden Finance reports that on July 25, the U.S. startup Science Corp. has been approved to sell in the EU a retinal chip that can help “geographic atrophy”(GA) patients restore some vision. This is the first time the relevant device from a U.S. brain-computer interface (BCI) company has been rolled out at scale to the patient market, and it is an important milestone for the company toward BCI commercialization. Its long-term goal is to bring brain-implant devices to the market. According to Science Corp., its PRIMA brain-computer system is a new type of subretinal photovoltaic implant used together with dedicated eyeglasses. The glasses project near-infrared light onto the implant and convert it into electrical stimulation signals; the “amplification” feature allows patients to enlarge text. The implant is ultra-thin and enables seamless wireless integration.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned